St. Louis startup Geneoscopy, developer of colon cancer test, inks distribution deal

St. Louis gastrointestinal health startup Geneoscopy Inc. has partnered with a major health care diagnostics firm to distribute the screening test for colorectal cancer it soon plans to begin commercializing.

Previous Banks in South Florida
Next Oregon's addiction crisis: A drop in risky drug prescribing is a rare bright spot